Vaxil’s Annual and Special Shareholders Meeting

Provided By Globe Newswire

Last update: Apr 25, 2023

Not for distribution by US newswire or in United States

NESS-ZIONA, Israel, April 24, 2023 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative immunotherapy biotech company specializing in cancer and infectious diseases, announces that at the Company's Annual and Special General Meeting, held virtually, on April 20, 2023, all resolutions were duly passed by shareholders.